Overview
What is American Society For Pharmacology & Experimental Therapeutics?
The American Society for Pharmacology & Experimental Therapeutics (ASPET) is a distinguished scientific organization with approximately 4,000 members globally. Based in Rockville, Maryland, ASPET's mission lies in fostering comprehensive pharmacological research, encompassing academia, government, large pharmaceutical companies, small biotech firms, and non-profit organizations. ASPET advances this mission through the publication of various scientific and educational journals, such as the Journal of Pharmacology and Experimental Therapeutics, Pharmacological Reviews, Molecular Pharmacology, Drug Metabolism and Disposition, and The Pharmacologist. These publications cover a broad spectrum of pharmacological topics, from interactions with biological systems to toxicology and chemotherapy. The society's quarterly publication, The Pharmacologist, serves to inform its members about society affairs and other relevant professional matters. ASPET's primary aim is to promote knowledge and advancement in the field of pharmacology, ultimately contributing to improved human health.
Official website here: www.aspet.org
Is American Society For Pharmacology & Experimental Therapeutics legitimate?
American Society For Pharmacology & Experimental Therapeutics is a legitimate nonprofit organization registered as a 501(c)(3) entity. American Society For Pharmacology & Experimental Therapeutics submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $385,938
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,467,625
For more financial information, click here
Official website here: www.aspet.org
What is the mission statement of American Society For Pharmacology & Experimental Therapeutics?
The American Society for Pharmacology & Experimental Therapeutics (ASPET) serves as a scientific society comprising approximately 4,000 members who engage in both basic and clinical pharmacological research. Their work spans various sectors, including academia, government, large pharmaceutical companies, small biotech firms, and non-profit organizations. The mission of ASPET is centered around publishing scientific and educational journals and other materials for the pharmacological community. Notable publications under its umbrella include the Journal of Pharmacology and Experimental Therapeutics, Pharmacological Reviews, Molecular Pharmacology, Drug Metabolism and Disposition, and The Pharmacologist. These publications cover a wide range of topics, including interactions of chemicals with biological systems, chemotherapy, toxicology, and more. ASPET's publications aim to advance knowledge in pharmacology and address basic problems in the field.
Official website here: www.aspet.org
Who is the CEO of American Society For Pharmacology & Experimental Therapeutics?
David Jackson is the President of American Society For Pharmacology & Experimental Therapeutics.
Official website here: www.aspet.org
What is the revenue of American Society For Pharmacology & Experimental Therapeutics?
American Society For Pharmacology & Experimental Therapeutics's revenue in 2022 was $4,463,274.
Official website here: www.aspet.org
Who are the executives of American Society For Pharmacology & Experimental Therapeutics and what are their salaries?
The average compensation at American Society For Pharmacology & Experimental Therapeutics during 2022 was $80,590. There are 23 employees and 100 volunteers at American Society For Pharmacology & Experimental Therapeutics.
Here are 18 key members and their salaries:
- David Jackson (Executive Officer)
- Melissa Huston (Meetings Director)
- Maria Pasho (Publications Director)
- Catherine Fry (Education Director)
- Robert Stanley (Chief Financial Officer)
- Cecilia Stoute (Sales & Licencing)
- Lynne Harris (Director Of Marketing)
- Xinxin Ding (Secretary/Treasurer Elect) [Trustee/Director]
- Michael L Jarvis (President) [Trustee/Director]
- Namandje Bumpus (President Elect) [Trustee/Director]
- Margaret Gnegy (Past Predident) [Trustee/Director]
- Kathryn Cunningham (Secretary/Treasurer) [Trustee/Director]
- Carol Beck (Past Secretary/Treasurer) [Trustee/Director]
- Randy Hall (Councilor) [Trustee/Director]
- John Traynor (Councilor) [Trustee/Director]
- Nina Isoherranen (Councilor) [Trustee/Director]
- Charles France (Past President)
- Mary-Ann Bjornsti (Past Secretary/Treasurer)
Official website here: www.aspet.org
Where can I find the form 990 for American Society For Pharmacology & Experimental Therapeutics?
The American Society For Pharmacology & Experimental Therapeutics’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.aspet.org
Learn more at the official website: www.aspet.org
Mission Statement of American Society For Pharmacology & Experimental Therapeutics
The American Society for Pharmacology & Experimental Therapeutics (ASPET) is a prominent scientific society, boasting a membership of approximately 4,000 individuals. This organization is distinguished by its members who are engaged in conducting both basic and clinical pharmacological research. Their work spans various sectors, including academia, government, large pharmaceutical companies, small biotech firms, and non-profit organizations.
At the heart of ASPET's mission is the pursuit of knowledge in pharmacology and experimental therapeutics. This is achieved through the publication of a range of scientific and educational journals and other publications. Notable among these is the Journal of Pharmacology and Experimental Therapeutics, which covers topics such as chemical interactions with biological systems, analgesics, drug abuse, metabolism, and toxicology, among others. Additionally, ASPET publishes Pharmacological Reviews, a quarterly review journal focusing on pharmacology, experimental therapeutics, toxicology, and chemotherapy.
Moreover, ASPET publishes Molecular Pharmacology, a monthly publication that emphasizes research on drug action and selective toxicity at the molecular level. This journal combines original applications of biochemistry, biophysics, genetics, and molecular biology with pharmacological research to solve fundamental problems in pharmacology and toxicology. Another significant publication is Drug Metabolism and Disposition, which covers the fields of pharmacokinetics, pharmacodynamics, and mechanisms, as well as genetic, nutritional, or hormonal factors affecting the biological fate of chemicals.
In summary, the American Society for Pharmacology & Experimental Therapeutics (ASPET) is a dynamic organization dedicated to advancing pharmacological research. Through its publications, it provides a platform for scientists to share their findings and contribute to the broader understanding of pharmacology and experimental therapeutics.
Impact
This information is meant to be a general summary of American Society For Pharmacology & Experimental Therapeutics. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
The American Society For Pharmacology & Experimental Therapeutics (ASPET) has a significant impact on the field of pharmacology and experimental therapeutics. Through its activities, ASPET supports and promotes scientific research in academia, government, pharmaceutical companies, biotech firms, and nonprofit organizations.
One of the key ways ASPET contributes to the scientific community is through its publications. The society publishes several scientific and educational journals that cover a wide range of topics in pharmacology and experimental therapeutics. These publications include the Journal of Pharmacology and Experimental Therapeutics, which explores the interactions of chemicals with biological systems across various disciplines. Molecular Pharmacology focuses on research of drug action and toxicity at the molecular level, while Drug Metabolism and Disposition covers pharmacokinetics, pharmacodynamics, and toxicological consequences of xenobiotic metabolism. These publications play a crucial role in advancing knowledge and understanding in the field.
Overall, ASPET's activities and publications have a positive impact on the advancement of pharmacological research, contributing to the development of new treatments, drugs, and therapies that can ultimately improve health outcomes and patient care.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PUBLICATIONS
Revenue
$3,346,695
MEMBER DUES
Revenue
$341,633
SOCIETY MEETINGS
Revenue
$140,288
Organization Details
Founding Year
1933
Phone
(301) 634-7065
Principal Officer
David Jackson
Main Address
1801 ROCKVILLE PIKE SUITE 210, ROCKVILLE, MD, 20852
Website
www.aspet.org
NTEE Category
Code: E66P - Health
If you are a representative of American Society For Pharmacology & Experimental Therapeutics and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.